+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biogen Inc. - logo

Founded in 1978 Biogen Inc is a global biotechnology company with its headquarters in Cambridge, Massachusetts. In 2003 Biogen merged with Idec Pharmaceuticals to create Biogen Idec and acquired Syntonix Pharmaceuticals in 2007. In 2015 the company returned to its original name Biogen Inc and acquired Convergence Pharmaceuticals. Biogen focuses on drug discovery for a range of conditions including neuropathic pain, hemophilia, organ failure, neuromuscular disorders and oncology. Their product portfolio includes Rituxan, Avonex, Tecfidera and Eloctate.

From
TNF Alpha Inhibitors Market Report 2026 - Product Thumbnail Image

TNF Alpha Inhibitors Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Checkpoint Inhibitors Market Report 2026 - Product Thumbnail Image

Checkpoint Inhibitors Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
Anti-CD20 Antibody - Pipeline Insight, 2025 - Product Thumbnail Image

Anti-CD20 Antibody - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Biopharmaceuticals Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Biopharmaceuticals Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
From
Bio/Pharmaceutical Outsourcing Report, May 2025 - Product Thumbnail Image

Bio/Pharmaceutical Outsourcing Report, May 2025

  • Report
  • May 2025
  • 24 Pages
  • Global
From
Neuropathy Pain Treatment Market 2024-2028 - Product Thumbnail Image

Neuropathy Pain Treatment Market 2024-2028

  • Report
  • November 2023
  • 171 Pages
  • Global
From
From
Loading Indicator